Factors associated with colonization by carbapenem-resistant enterobacteria in oncological patients: a case-control study
DOI:
https://doi.org/10.26694/repis.v9i1.3760Palavras-chave:
Drug Resistance, Multiple, Infection Control, Risk Factors, Carbapenem-Resistant EnterobacteriaceaeResumo
Introduction: Colonization and infections caused by Carbapenemase Producing Enterobacteria (CPE) are a global problem, being associated with an increase in hospitalization time, costs for health services, and morbidity and mortality rates. Oncologic patients represent a group of special interest and there are few studies involving CPE colonization among these patients. Aim: to investigate factors associated with colonization in cancer patients. Outlining: Case-control study developed in a tertiary reference hospital in cancer treatment in Porto Alegre, Brazil, from January to December 2017. The population consisted of patients diagnosed with cancer in clinical or surgical hospitalization. Results: The univariate analysis showed that variables associated with colonization by CPE were age, male sex, tumors with bone type of surgical hospitalization, number of intra-hospital transfers since hospitalization, hospitalization time >30 days, ICU hospitalization in the last 30 days, ICU time more than 15 days, surgical procedure in the last 30 days, use of antibiotics in the last 30 days, presence of tumor wound, and KPC infection. After multivariate analysis, male sex, external hospital as origin, hospital stay longer than 30 days, antibiotic use in the last 30 days, and presence of tumor wound, remained associated with EPC colonization. Use of aminoglycosides, and linezolide were associated with CPE colonization. Implications: We identified variables associated with CPE colonization in oncologic patients. Our results may indicate actions to prevent CPE colonization and consequent development of infections.
Referências
Stephanie M, Pouch MJS. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence [Internet]. 2017 Ago [cited 2019 Apr 01]; 8(4):391-402, Available from: https://doi.org/10.1080/21505594.2016.1213472
Batchelder JI, Hare PJ, Mok WWK. Resistance-resistant antibacterial treatment strategies. Front Antibiot. [Internet]. 2023 [cited 2019 Apr 01]; 2:1093156. Available from: https://doi.org/10.3389/frabi.2023.1093156
Peres D, et all. Outbreak of KPC-producing Klebsiella pneumoniae at a Portuguese university hospital: Epidemiological characterization and containment measures. Porto Biomed J. [Internet]. 2022 [cited 2019 Apr 01]; 7(6):86. Available from: https://doi.org/10.1097/j.pbj.0000000000000186
ANVISA. Nota Técnica Nº 01/ 2013. Medidas de Prevenção e Controle de Infecções por Enterobactérias Multirresistentes. Brasília:ANVISA; 2013.
Patrice N, Laurent P, Laurent D. Rapid Detection of Carbapenemase-producing Enterobacteriaceae. Emerging Infec Dis J [Internet]. 2012 [cited 2019 Apr 01]; 18(9):1503. Available from: https://doi.org/10.3201/eid1809.120355
Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antim Chemotherapy [Internet]. 2012 [cited 2019 Apr 01]; 67(4):906-9. Available from: https://doi.org/10.1093/jac/dkr563
ANVISA. Critérios Diagnósticos de Infecções relacionadas à Assistência à Saúde. Agência Nacional de Vigilância Sanitária. Brasília: ANVISA; 2017.
Campos JCM, Antunes LCM, Ferreira RBR. Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options. Future Microbiology [Internet]. 2020 [cited 2019 Apr 01]; 15: 649-677. Available from: https://doi.org/10.2217/fmb-2019-0333
Marimuthu K, Ng OT, Cherng BPZ, Fong RKC, Pada SK, De PP, et al. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae. Antimicrob Agents Chemother [Internet]. 2019 [cited 2019 Apr 01]; 63(10):845-19. Available from: https://doi.org/10.1128/AAC.00845-19
Wilson H, Török ME. Extended- spectrum β- lactamase- producing and carbapenemase -producing Enterobacteriaceae. Microbial Genomics [Internet]. 2018 [cited 2019 Apr 01]; 4(7):1-12. Available from: https://doi.org/10.1099/mgen.0.000197
Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, et al. Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. EBioMedicine [Internet]. 2017 [cited 2019 Apr 01]; 19:98-106. Available from: https://doi.org/10.1016/j.ebiom.2017.04.032
Silva KE, Maciel WG, Sacchi FP, Carvalhaes CG, Rodrigues Costa F, da Silva AC, et al. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol [Internet]. 2016 [cited 2019 Apr 01]; 65(6):547-53. Available from: https://doi.org/10.1099/jmm.0.000254
Kofiteridis DP , Valachis A, Dimoupoulou D, Maraki S, Mantadakis E, Mantadakis E, Samonis G. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case case-control study . J Infect Chemother [Internet]. 2014 [cited 2019 Apr 01]; 20:293- 297. Available from: https://doi.org/10.1016/j.jiac.2013.11.007
Madney Y, Aboubakr S, Khedr R, Hafez H, Ahmed N, Elsheshtawy K, Elanany M, Salahelden A, Shalaby L, Galal Behairy O. Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome. Antibiotics (Basel) [Internet]. 2013 [cited 2019 Apr 01]; 12(2):405. Available from: https://doi.org/10.3390/antibiotics12020405
Thomas Howe M, Sean Berger S, Angela G-S, Susan W, Anne-Catrin U. Carbapenem resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90- day mortality in critically ill patients, an observational study. PLoS ONE [Internet]. 2017 [cited 2019 Apr 01]; 12(10):0186195. Available from: https://doi.org/10.1371/journal.pone.0186195
Madueño A, González GJ, Ramos MJ, Pedroso Y, Díaz Z, Oteo J, et al. Risk factors associated with carbapenemase-producing Klebsiella pneumoniae fecal carriage: A case–control study in a Spanish tertiary care hospital. American Journal of Infection Control [Internet]. 2017 [cited 2019 Apr 01]; 45(1):77-9. Available from: https://doi.org/10.1016/j.ajic.2016.06.024
Ting S-W, Lee C-H, Liu J-W. Risk factors and outcomes for the acquisition of carbapenem resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study. J Microb, Immun Infec [Internet]. 2018 [cited 2019 Apr 01]; 51(5):621-8. Available from: https://doi.org/10.1016/j.jmii.2016.08.022
Schwartz-Neiderman A, Braun T, Fallach N, Schwartz D, Carmeli Y, Schechner V. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients. Infec Cont Hosp Epidem [Internet]. 2016 [cited 2019 Apr 01]; 37(10):1219-25. Available from: https://doi.org/10.1017/ice.2016.153
McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae. Antim Agents Chemotherapy [Internet]. 2013 [cited 2019 Apr 01]; 57(10):5131. Available from: https://doi.org/10.1128/AAC.00607-13
Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, Leal-Vega F, Cruz-Hervert LP, Garcia-Garcia L, et al. Factors Associated to Prevalence and Incidence of Carbapenem- Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.(Report) [Internet]. 2015 [cited 2019 Apr 01]; 10(10):1-12. Available from: https://doi.org/10.1371/journal.pone.0139883
Maseda E, Salgado P, Anillo V, Ruiz-Carrascoso G, Gómez-Gil R, Martín-Funke C, et al. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study. Enferm Infecc Microbiol Clin [Internet]. 2017 [cited 2019 Apr 01]; 35(6):333-7. Available from: https://doi.org/10.1016/j.eimc.2016.02.017
Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance. Clin Microbiol Rev [Internet]. 2013 [cited 2019 Apr 01]; 26(2):289. Available from: https://doi.org/10.1128/CMR.00001-13
Darling LA, Evans AM, Stellrecht KA, Nattanmai SM, Montero CI. A Triple-Disk Enrichment Method for Carbapenem-Resistant Enterobacteriaceae (CRE) Screening. J Clin Microbiol [Internet]. 2017 [cited 2019 Apr 01]; 55(12):3557-3559. Available from:
https://doi.org/10.1128/JCM.01185-17
Zhou C, Chen X, Wu L, Qu J. Distribution of drug-resistant bacteria and rational use of clinical antimicrobial agents. Exp Ther Med [Internet]. 2016 [cited 2019 Apr 01]; 11:2229-2232. Available from: https://doi.org/10.3892/etm.2016.3239
Richter SS, Marchaim D. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How? Virulence [Internet]. 2017 [cited 2019 Apr 01]; 8(4):417-426. Available from: https://doi.org/10.1080/21505594.2016.1255381
